Pfizer Says Its Antiviral Pill Slashes Risk of Severe Covid By 89%
Pfizer Inc’s (PFE.N) experimental antiviral pill to treat COVID-19 cut by 89% the chance of hospitalization or death for adults at risk of severe disease, the company said on Friday,